Coexpression of CD40 and class II antigen HLA-DR in Graves' disease thyroid epithelial cells

Clinical Immunology and Immunopathology

Volumn 84, Issue 2, 1997, Pages 212-215

  Faure, Gilbert Charles ^a   Bensoussan Lejzerowicz, Danièle ^a   Bene, Marie Christine ^a   Aubert, Valérie ^a   Leclere, Jacques ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; ETIOLOGY; FEMALE; GRAVES DISEASE; HLA SYSTEM; HUMAN; HUMAN CELL; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; THYROID DISEASE;

EID: 0031214805     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4391     Document Type: Article

References (27)

1. Feliciano D. V. Everything you wanted to know about Graves' disease. Am. J. Surg. 164:1992;404-411.
2. Hanafusa T., Chiovato L., Doniach D., Pujol-Borrell R., Russell R. C. G., Bottazzo G. F. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: Relevance for autoimmunity. Lancet. 12:1983;1111-1115.
3. Bottazzo G. F., Pujol-Borrell R., Hanafusa T. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet. 12:1983;1115-1118.
4. Jansson R., Karlsson A., Forsum U. Intrathyroidal HLA-DR expression and T lymphocyte phenotype in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre. Clin. Exp. Immunol. 58:1984;264-272.
5. Todd I., Pujol-Borrell R., Hammond L. J., Bottazzo G. F., Feldmann M. Interferon-gamma induces HLA-DR expression by thyroid epithelium. Clin. Exp. Immunol. 61:1985;265-273.
6. Leclère J., Béné M. C., Duprez A., Faure G., Thomas J. L., Vignaud J. M., Burlet C. Behaviour or thyroid tissue from patients with Graves' disease in nude mice. J. Clin. Endocrinol. Metab. 59:1984;175-177.
7. Bottazzo G. F., Dean B. M., McNally J. M., Mackay E. H., Swift P. G., Gamble D. R. In situ characterization of auto-immune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. New Engl. J. Med. 313:1985;353-360.
8. Lindahl G., Hedfors E., Klareskog L., Forsum U. Epithelial HLA-DR expression and T-lymphocyte subsets in salivary glands in Sjögren's syndrome. Clin. Exp. Immunol. 61:1985;475-482.
9. El Kaissouni J., Béné M. C., Faure G. C. Investigation of activation markers demonstrates significant overexpression of the secretory component on salivary glands epithelial cells in Sjögren's syndrome. Clin. Immunol. Immunopathol. 79:1996;236-243.
10. Béné M. C., Derennes V., Faure G., Thomas J. L., Duheille J., Leclère J. Graves' disease: In situ localization of lymphoid T-cells subpopulations. Clin. Exp. Immunol. 53:1983;311-316.
11. Matzinger P. Tolerance, danger and the extended family. Annu. Rev. Immunol. 12:1994;991-1045.
12. Gavrieli Y., Sherman Y., Ben-Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol. 119:1992;493-501.
13. Lucas-Martin A., Foz-Sala M., Todd I., Botazzo G. F., Pujol-Borrel R. Occurrence of thyrocyte HLA-class II expression in wide variety of thyroid diseases, relationship with lymphocytic infiltration and thyroid antibodies. J. Clin. Endocrinol. Metab. 66:1988;367-375.
14. Tanimoto C., Hirakawa S., Kawasaki H., Hayakawa N., Ota Z. Apoptosis in thyroid diseases, a histochemical study. Endocrine J. 42:1995;193-201.
15. Banchereau J., Bazan F., Blanchard D., Brière F., Galizzi J. P., van Kooten C., Liu Y. J., Rousset F., Saeland S. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:1994;881-922.
16. Katira A., Holder M., Pound J., Gordon J. CD40 workshop panel report. Leucocyte Typing V: White Cells Differentiation Antigens. 1995;Oxford Univ. Press, Oxford. p. 547-550.
17. Stamenkovic I., Clark E. A., Seed B. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 8:1989;1403-1410.
18. Caux C., Massacrier C., Vanbervliet B., Dubois B., Van Kooten C., Durand I., Banchereau J. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 178:1993;669-674.
19. Pammer J., Piettenberg A., Weninger W., Diller B., Mildner M., Uthman A., Issing W., Stürzl M., Tschachler E. CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma. Am. J. Pathol. 148:1996;1387-1396.
20. Galy A. H., Spits H. CD40 is functionally expressed on human thymic epithelial cells. J. Immunol. 149:1992;775-781.
21. Graf D., Korthauer U., Mages H. W., Senger G., Kroczek R. A. Cloning of TRAP, a ligand for CD40 on human T cells. Eur. J. Immunol. 22:1992;3191-3194.
22. Carbone A., Goghini A., Gruss H. J., Pinto A. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease. Am. J. Pathol. 147:1995;912-922.
23. June C. H., Bluestone J. A., Nadler L. M., Thomson C. B. The B7 and CD28 receptors families. Immunol. Today. 15:1994;321-331.
24. Windhagen A., Newcombe J., Dangond F., Strand C., Woodroofe M. N., Cuzner M. L., Hafle D. A. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182:1995;1985-1996.
25. Ranheim E. A., Kipps T. J. Elevated expression of CD80 (B7/BB1) and other accessory molecules on synovial fluid mononuclear cell subsets in rheumatoid arthritis. Arthritis Rheum. 37:1994;1637-1646.
26. Khoury S. J., Akalin E., Chandraker A., Turka L. A., Linsley P. S., Sayegh M. H., Hancock W. W. CD28-B7 costimulatory lockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J. Immunol. 155:1995;4521-4524.
27. Agathanggelou A., Niedobitek G., Chen R., Nicholls J., Yin W., Young L. S. Expression of immune regulatory molecules in Epstein Barr virus associated nasopharyngeal carcinomas with prominent lymphoid stroma: Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells. Am. J. Pathol. 147:1995;1152-1160.